Moneycontrol
HomeNewsTechnologyAutoIndia auto hub lets car plants run at full capacity despite few vaccinations
Trending Topics

India auto hub lets car plants run at full capacity despite few vaccinations

India's southern Tamil Nadu state, known for its flourishing automobile industry, on Sunday allowed some industrial units including those of global automakers in and around capital city Chennai to operate at 100% capacity.

June 21, 2021 / 07:36 IST
Story continues below Advertisement
India's southern Tamil Nadu state, known for its flourishing automobile industry, on Sunday allowed some industrial units including those of global automakers in and around capital city Chennai to operate at 100% capacity.

Car factories, including those of Renault-Nissan, Hyundai and Ford, can operate with full workforces in India's automaking hub from Monday, even though 75% of workers at the global carmakers' plants have not been vaccinated against COVID-19.

India's southern Tamil Nadu state, known for its flourishing automobile industry, on Sunday allowed some industrial units including those of global automakers in and around capital city Chennai to operate at 100% capacity.

Story continues below Advertisement

The move follows a Tamil Nadu Directorate of Industrial Safety and Health report dated 18 June, reviewed by Reuters, which shows three in four workers at the plants of Ford, Hyundai and Renault-Nissan near Chennai have not been vaccinated against COVID-19.

Of those who were vaccinated, the report did not say how many had received one dose and how many had received two.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show